United States Neuroscience Market Size, Share, and COVID-19 Impact Analysis, By Component (Instruments, Consumables, and Software & Services), By Technology (Brain Imaging, Neuro-Microscopy, Stereotaxic surgeries, Neuro-Proteomic Analysis, Neuro-Cellular Manipulation, and Others), and United States Neuroscience Market Insights, Industry Trend, Forecasts to 2035

United States Neuroscience Market Size Insights Forecasts to 2035

• The US Neuroscience Market Size Was Estimated at USD 11,907.9 Million in 2024
• The Market Size is Expected to Grow at a CAGR of around 5.38% from 2025 to 2035
• The US Neuroscience Market Size is Expected to Reach USD 21,199.6 Million by 2035

According to a Research Report Published by Spherical Insights & Consulting, the United States Neuroscience Market Size is anticipated to reach USD 21,199.6 million by 2035, growing at a CAGR of 5.38% from 2025 to 2035. The expansion of the United States neuroscience market is propelled by the rise in neurological diseases like alzheimer's, epilepsy, traumatic brain traumas, brain cancer, and others are among the contributing factors.

Market Overview

Neuroscience is an interdisciplinary scientific field that studies the anatomy, function, development, and malfunction of the nervous system, particularly the brain and spinal cord. In 2023, the United States held a share of more than 27.0% share in the neuroscience market.  The market is expected to continue its growth with increasing efforts from various organisations. For example, the charity Bee Foundation (TBF) uses cutting-edge science to raise awareness and lower the number of deaths caused by brain aneurysms. To assist the TBF in achieving its central goal of reducing deaths from brain aneurysms, the TBF is looking for research proposals. These factors should provide a boost to the market over the forecast period.  Additionally, according to the Brain Aneurysm Foundation, there are approximately 6.5 million individuals in the U.S. living with an unruptured brain aneurysm. Furthermore, an estimated 30,000 people each year experience the rupture of an intracranial aneurysm. The National Institute of Health estimates that there are about 795,000 strokes in the United States each year, which equates to about 137,000 deaths. So, as the number of neurological disorders increases in the country, it will likely drive growth in the market. Additionally, attractive reimbursement regulations and higher health expenditures will promote market expansion.

Report Coverage

This research report categorizes the market for the United States neuroscience market based on various segments and regions and forecasts revenue growth and analyses trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the United States neuroscience market. Recent market developments and competitive strategies such as expansion, product launch, development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the United States neuroscience market.

Driving Factors

The growth of the United States neuroscience market is boosted by non-invasive brain-computer interfaces (BCIs), which are transforming the neuroscience market and providing accessible, low-cost options for assistive technology and rehabilitation technologies. The BCIs allow connection directly from the brain without surgery. For individuals with motor impairments that are acquired through neurological disorders like stroke, cerebral palsy, and spinal cord injury, delivering practical applications is highly encouraging. Non-invasive EEG-based solutions are rapidly growing in value in aiding them to recover motor function, communication, and even quality of life.

Restraining Factors

The United States neuroscience market faces obstacles, like for startups as smaller universities, the high costs of neuroimaging, device development, and late-stage clinical trials limit access and put pressure on finances. Product commercialisation is further delayed by stringent FDA rules and protracted approval processes.

Market Segmentation

The United States neuroscience market share is classified into component and technology.

• The instruments segment held the largest market share in 2024 and is expected to grow at a remarkable CAGR during the forecast period.

The United States neuroscience market is segmented by component into instruments, consumables, and software & services. Among these, the instruments segment held the largest market share in 2024 and is expected to grow at a remarkable CAGR during the forecast period. The segment is driven by the growing need for sophisticated surgical and diagnostic equipment. To address the growing prevalence of neurological illnesses, advanced neurostimulation technologies, neurosurgical instruments, and neuroimaging systems (MRI, CT, PET) are crucial. Regulatory reimbursements, high-precision devices, and ongoing innovation have solidly established this segment's market leadership.

• The brain imaging segment held the highest revenue share in 2024 and is expected to grow at a significant CAGR during the forecast period.

Based on the technology, the United States neuroscience market is segmented into brain imaging, neuro-microscopy, stereotaxic surgeries, neuro-proteomic analysis, neuro-cellular manipulation, and others. Among these, the brain imaging segment held the highest revenue share in 2024 and is expected to grow at a significant CAGR during the forecast period. The segmental growth is propelled by hospitals, ambulatory surgery centres, and diagnostic centres that will use brain imaging applications using tools like CT scans, MRIs, and EEGs to diagnose neurological problems. MRI is gaining acceptability and usefulness for scanning and analysing brain tumours and other neurological disorders.

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the United States neuroscience market, along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborate analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

List of Key Companies

• Danaher Corp
• Boston Scientific Corp
• Stryker Corp
• Abbott Laboratories
• GE HealthCare Technologies Inc
• Siemens Healthineers
• Johnson & Johnson MedTech
• Carl Zeiss AG
• Medtronic
• Others

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting and Research Firm
• Venture capitalists
• Value-Added Resellers (VARs)

Market Segment

This study forecasts revenue at the United States, regional, and country levels from 2020 to 2035. Spherical Insights has segmented the United States neuroscience market based on the following segments:

United States Neuroscience Market, By Component

• Instruments
• Consumables
• Software & Services

United States Neuroscience Market, By Technology

• Brain Imaging
• Neuro-Microscopy
• Stereotaxic surgeries
• Neuro-Proteomic Analysis
• Neuro-Cellular Manipulation
• Others